Barclays Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $4
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Saket Kalia maintains an Equal-Weight rating on Definitive Healthcare (NASDAQ:DH) but lowers the price target from $6 to $4.
August 07, 2024 | 4:50 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays has maintained an Equal-Weight rating on Definitive Healthcare but has lowered the price target from $6 to $4.
The lowering of the price target from $6 to $4 by Barclays suggests a negative outlook on the stock's short-term performance, which is likely to put downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100